NMS-03592088

N/A

Report date: 2024/09/20 20:00:41

NME

Base Information

Drug NameNMS-03592088

Drug Alias NameNMS-P088NMS-03592088

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionStem cell growth factor receptor inhibitorsTyrosine-protein kinase receptor FLT3 inhibitorsColony stimulating factor 1 receptor inhibitors

TargetsStem cell growth factor receptorColony stimulating factor 1 receptorTyrosine-protein kinase receptor FLT3

Therapy Area/IndicationsLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItalyFranceSpain

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNerviano Medical Sciences Srl

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNerviano Medical Sciences Srl

Active IndicationsN/A

Inactive IndicationsLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A